Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

NCT01625182 ·Status: COMPLETED ·Phase: PHASE3

A Study of CDX-0159 in Patients With Prurigo Nodularis

NCT04944862 ·Status: COMPLETED ·Phase: PHASE1

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

NCT00004772 ·Status: COMPLETED ·Phase: PHASE3

Ruxolitinib Treatment in Inclusion Body Myositis

NCT06536166 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

NCT06774664 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Phase I Clinical Trial of Meplazumab in Healthy Volunteer

NCT04369586 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers

NCT04220073 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141 ·Status: RECRUITING ·Phase: PHASE3

Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

NCT01423110 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica

NCT00982332 ·Status: UNKNOWN ·Phase: NA

Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy

NCT04062019 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Stapokibart for Primary Cutaneous Amyloidosis

NCT07143864 ·Status: NOT_YET_RECRUITING ·Phase: NA

Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.

NCT00809822 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

NCT06920004 ·Status: RECRUITING ·Phase: PHASE3

Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis

NCT05177939 ·Status: UNKNOWN ·Phase: PHASE3

Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy

NCT05833711 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04281472 ·Status: COMPLETED ·Phase: PHASE2

An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis

NCT06645197 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Iguratimod in Systemic Sclerosis

NCT04515706 ·Status: UNKNOWN ·Phase: NA

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

NCT04540497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Phase I Study of Recombinant Human Nerve Growth Factor Injection

NCT04232332 ·Status: UNKNOWN ·Phase: PHASE1

Study of CM313 in Subject With IgA Nephropathy

NCT06830395 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT06325943 ·Status: COMPLETED ·Phase: PHASE3

Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects

NCT07054034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

NCT00004286 ·Status: COMPLETED ·Phase: PHASE3